FDA recall, , Moderate risk
Unichem Amiodarone Hydrochloride Tablets
Unichem Amiodarone Hydrochloride Tablets contain a foreign substance.
What happened
Unichem Pharmaceuticals USA Inc. of East Brunswick, New Jersey, is recalling 23,850 bottles of Unichem Amiodarone Hydrochloride Tablets, USP, because of the presence of a foreign substance. The recall was started by the company on its own. Customers were told about it by letter.
The tablets are 200 mg, sold in bottles of 60 tablets. The label says the tablets are for prescription use only. The label says they were manufactured by Unichem Laboratories Ltd. in Ghaziabad, India. The product was distributed nationwide in the United States. The Food and Drug Administration added the recall to its Enforcement Report on November 13, 2026.
What to do
If a code on your package is listed below:
- Don't stop taking it without talking to your pharmacist or doctor; ask them whether your lot is recalled.
Typical advice for a recalled medicine; the FDA notice gives no product-specific instructions.
Is yours affected?
Match the lot code and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Amiodarone Hydrochloride Tablets, USP
- Strength
- 200 mg
- NDC
- 29300-359-16
- Lot code
- ZMRH25054
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 9, 2026
- Sold in
Distributed nationwide.
- Recalled by
- Unichem Pharmaceuticals USA Inc.East Brunswick, New Jersey
- Hazard
- Foreign object
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100290
- Recall number
- D-0183-2027
- Quantity recalled
- 23,850 bottles
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from Unichem Pharmaceuticals USA Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Unichem Pharmaceuticals USA Inc. began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary



